Other headlines:TomoTherapy changes Siemens supply agreementGE strikes PET deal with Brigham and Women’s Johnson joins InSite One
Philips Healthcare escaped the first quarter with a scant 2% decline in revenues compared with the year-earlier period, a slight drop compared with double-digit declines in the company's consumer lifestyle and lighting divisions. The modest size of the drop was achieved largely on the coattails of gains in home healthcare and through sales in emerging markets overseas, especially in Central and Eastern Europe, the Middle East, and India. The company noted lower sales at Imaging Systems, Healthcare Informatics/Patient Monitoring, and Clinical Care Systems. Chief Executive Gerard Kleisterlee said the company's healthcare group is facing a very soft U.S. hospital market but will continue "to execute its strategy to further build leadership in Health and Well-being, maintaining investments in R&D, marketing, and small acquisitions."
On April 10, 2009, TomoTherapy amended its manufacture and supply agreement with Siemens for the manufacture, purchase, and sale of linear accelerators and related components. The amendment, which itself took effect April 1, 2009, but extends retroactively to Oct. 8, 2008, cuts the maximum price that Siemens can charge TomoTherapy to repair out-of-warranty linear accelerator assemblies. The amendment also provides that if a linear accelerator assembly cannot be repaired, as determined by both Siemens and TomoTherapy, then Siemens will issue a specified credit for the scrap value of the material. It adds to the warranty provision that repaired out-of-warranty accelerator assemblies are warranted for 12 months from the date of delivery.
GE Healthcare has signed a research agreement with Brigham and Women's Hospital to transition PET developments into clinical applications. Staff from GE and the 777-bed teaching affiliate of Harvard Medical School plan to focus on developing personalized approaches to the diagnosis and management of patients with oncologic, neurologic, and cardiovascular diseases.
Douglas L. Johnson has joined InSite One as director of enterprise storage solutions. Johnson, who has 30 years' experience in sales and marketing, will focus on integrated delivery networks and large hospitals whose requirements are addressed by InSite One's InDex enterprise archive and storage consolidation technologies.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.